Fatty liver capsules treatment of non-alcoholic fatty liver disease clinical study.docVIP

 PAGE \* MERGEFORMAT 13 Fatty liver capsules treatment of non-alcoholic fatty liver disease clinical study Of: Liu Xuerong, Qi Zhong Xi Geng blue book [Abstract] Objective To investigate the fatty liver capsules of non-alcoholic fatty liver disease patients. Methods 120 cases of non-alcoholic fatty liver disease were randomly divided into 2 groups, an increase in the amount of exercise and proper diet control, based on the treatment group received fatty liver capsules, tablets dongbaogantai control group, 4 months after treatment and adverse effects were evaluated. Results The cure rate in treatment group and the total effective rate was 51.67%, 93.33% in the control group were 13.34%, 53.33%, the difference was statistically significant (P lt;0.01). the treatment group to improve the main clinical symptoms, liver function, blood lipids, and imaging aspects, such as different degrees of change than the control group .2 group were not found adverse effects. Conclusion fat Liver Capsules on non-alcoholic fatty liver disease is effective, no obvious side effects and toxicity. [Keywords:] non-alcoholic fatty liver disease; hyperlipidemia; liver and spleen disharmony; phlegm; fatty liver capsules Abstract: Objective To observe the effect of herbal recipe Zhiganqing capsule (ZGQ capsule) in treating non-alcoholic fatty liver disease (NAFLD). Methods One hundred and twenty NAFLD patients were divided into two groups randomly. On the basis of diet control and increasing exercise, the treating group was treated with ZGQ capsule, and the control group was treated with Dongbao Gantai pill. The effect and side effects were observed after 4 months. Results The curing rate and total effective rate of treatment group and control group were 51.67% , 93.33% and 13.34%, 53.33% respectively, the difference between the two groups was significant (P lt;0.01). As compared with control group, ZGQ capsule could improve the symptoms, liver function, hyperlipemia and the ult